Prostate Sarcoma – A Diagnostic Challenge Initially Suspected as Prostatitis

Authors

DOI:

https://doi.org/10.59667/sjoranm.v20i1.16

Keywords:

Prostatic sarcoma, infiltrative unstable, partially CD34 + sarcoma, atypical or refractory urological symptoms

Abstract

Prostatic sarcoma can mimic benign urological disease and delay diagnosis. A 42-year-old man presented with urinary symptoms and pelvic pain and was initially treated for suspected prostatitis. CT and multiparametric MRI demonstrated an extensive prostatic mass with adjacent-organ invasion and obstructive uropathy. Histopathological evaluation subsequently established a partially CD34-positive sarcoma without further classification; staging revealed hepatic metastases. Doxorubicin and ifosfamide produced an initial partial response, followed by pelvic exenteration. Local recurrence and metastatic progression subsequently occurred despite gemcitabine/docetaxel and pazopanib. The patient died in June 2023. This case highlights the diagnostic value of imaging and tissue assessment in atypical or persistent urological presentations and the aggressive clinical course that may occur despite multidisciplinary treatment.

References

1) Herlemann A, Horst D, D’Anastasi M, Kretschmer A, Stief CG, Gratzke C. Das primäre Prostatasarkom – ein seltenes Malignom. Der Urologe. 2017;56(7):857–860. https://doi.org/10.1007/s00120-017-0370-z DOI: https://doi.org/10.1007/s00120-017-0370-z

2) Alfaro-Cervelló C, Nieto G, Navarro S. Differential diagnosis of myxoid soft tissue tumors. Experience in the Clinical University Hospital of Valencia. Revista Española de Patología. 2022;55(3):185–191. https://doi.org/10.1016/j.patol.2019.07.005 DOI: https://doi.org/10.1016/j.patol.2019.07.005

3) Yang W, Liu A, Wu J, Niu M. Prostatic stromal sarcoma. Medicine. 2018;97(18):e0495. https://doi.org/10.1097/MD.0000000000010495 DOI: https://doi.org/10.1097/MD.0000000000010495

4) Steen S, Stephenson G. Current treatment of soft tissue sarcoma. Baylor University Medical Center Proceedings. 2008;21(4):392–396. https://doi.org/10.1080/08998280.2008.11928435 DOI: https://doi.org/10.1080/08998280.2008.11928435

5) American Cancer Society. Chemotherapy for Soft Tissue Sarcomas [Internet]. https://www.cancer.org/cancer/types/soft-tissue-sarcoma/treating/chemotherapy.html

6) Maki RG. Gemcitabine and docetaxel in metastatic sarcoma: past, present, and future. The Oncologist. 2007;12(8):999–1006. https://doi.org/10.1634/theoncologist.12-8-999 DOI: https://doi.org/10.1634/theoncologist.12-8-999

7) Sarcoma UK. Soft tissue sarcoma survival [Internet]. 2024 [cited 2025 Apr 21]. https://sarcoma.org.uk/about-sarcoma/soft-tissue-sarcoma-data-hub/soft-tissue-sarcoma-survival/

SJORANM article cover, Vol. 20 No. 1 (2025). Holographic symbolic illustration for article 66.

Published

2025-06-20

Data Availability Statement

All data generated or analyzed during this study are available from the corresponding author upon reasonable request. The datasets supporting the conclusions of this article have been securely archived and can be accessed for further assessment, subject to ethical and legal considerations. This work has been published in the Swiss Journal of Radiology and Nuclear Medicine.

Issue

Section

Case reports

How to Cite

Weiss, D., Bischoff, A., Takla, T., Mack, V., & Maurer, M. H. (2025). Prostate Sarcoma – A Diagnostic Challenge Initially Suspected as Prostatitis. Swiss Journal of Radiology and Nuclear Medicine, 20(1), 31-35. https://doi.org/10.59667/sjoranm.v20i1.16

Share

Similar Articles

21-29 of 29

You may also start an advanced similarity search for this article.

Most read articles by the same author(s)